Albireo Competitors

Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Albireo Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Albireo Pharma in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
32.3844.5956.80
Details
Intrinsic
Valuation
LowReal ValueHigh
40.2652.4764.68
Details
Naive
Forecast
LowNext ValueHigh
25.5537.7649.98
Details
5 Analysts
Consensus
LowTarget PriceHigh
67.0075.8084.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Albireo Pharma. Your research has to be compared to or analyzed against Albireo Pharma's peers to derive any actionable benefits. When done correctly, Albireo Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Albireo Pharma.

Albireo Pharma Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Albireo Pharma and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Albireo and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Albireo Pharma does not affect the price movement of the other competitor.

Related Correlations

NVTS
SCPL
ON
CNLFF
PLYA
HHUSF
CSGU
NVTS
0.270.850.280.570.050.0
NVTS
SCPL
0.270.360.550.660.620.0
SCPL
ON
0.850.360.030.380.180.0
ON
CNLFF
0.280.550.030.810.420.0
CNLFF
PLYA
0.570.660.380.810.460.0
PLYA
HHUSF
0.050.620.180.420.460.0
HHUSF
CSGU
0.00.00.00.00.00.0
CSGU
NVTS
SCPL
ON
CNLFF
PLYA
HHUSF
CSGU
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Risk-Adjusted Indicators

Nowadays, there is a big difference between Albireo Stock performing well and Albireo Pharma company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Albireo Pharma's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Cross Equities Net Income Analysis

Select Fundamental

20102011201220132014201520162017201820192020202120222023
ON290.5 M11.6 M(90.6 M)150.8 M189.7 M206.2 M182.1 M810.7 M627.4 M211.7 M234.2 MB908.6 M980.4 M

Albireo Pharma and related stocks such as Navitas Semiconductor, Sciplay Corp, ON Semiconductor, Canlan Ice Sports, Playa Hotels Resorts, Hua Hong Semiconductor, and Consolidated Sports Media Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Albireo Pharma financial statement analysis. It represents the amount of money remaining after all of Albireo Pharma operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Albireo Pharma Competitive Analysis

The better you understand Albireo Pharma competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Albireo Pharma's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Albireo Pharma's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ALBONVTSSCPLONCNLFFPLYAHHUSFCSGU
 0.80 
 44.59 
Albireo
 2.59 
 5.65 
Navitas
 1.39 
 16.29 
Sciplay
 0.61 
 80.40 
ON Semiconductor
 0.00 
 2.97 
Canlan
 0.79 
 7.57 
Playa
 33.74 
 4.36 
HHUSF
 0.00 
 0.0001 
Consolidated
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Number of Shares Shorted
Shares Owned by Insiders
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Cash Flow from Operations
Retained Earnings
Current Asset
Beta
Price to Book
Shares Outstanding
Total Debt
Return On Equity
Price to Earning
Z Score
Shares Owned by Institutions
Return On Asset
Book Value Per Share
Cash and Equivalents
Current Liabilities
Price to Earnings To Growth
Total Asset
Short Ratio
Target Price
Last Dividend Paid
Price to Sales
Market Capitalization
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Revenue
Working Capital
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Albireo Pharma Competition Performance Charts

Complement your Albireo Pharma position

In addition to having Albireo Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Banks Thematic Idea Now

Banks
Banks Theme
Large and small money and credit banks and credit services. The Banks theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Banks Theme or any other thematic opportunities.
View All  Next Launch
Please continue to Albireo Pharma Correlation with its peers. Note that the Albireo Pharma information on this page should be used as a complementary analysis to other Albireo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Albireo Stock analysis

When running Albireo Pharma price analysis, check to measure Albireo Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Albireo Pharma is operating at the current time. Most of Albireo Pharma's value examination focuses on studying past and present price action to predict the probability of Albireo Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Albireo Pharma's price. Additionally, you may evaluate how the addition of Albireo Pharma to your portfolios can decrease your overall portfolio volatility.
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Bond Directory
Find actively traded corporate debentures issued by US companies
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
CEO Directory
Screen CEOs from public companies around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Albireo Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Albireo Pharma. If investors know Albireo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Albireo Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
922.9 M
Quarterly Revenue Growth
1.683
Return On Assets
(0.25) 
Return On Equity
(0.93) 
The market value of Albireo Pharma is measured differently than its book value, which is the value of Albireo that is recorded on the company's balance sheet. Investors also form their own opinion of Albireo Pharma's value that differs from its market value or its book value, called intrinsic value, which is Albireo Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Albireo Pharma's market value can be influenced by many factors that don't directly affect Albireo Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Albireo Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Albireo Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Albireo Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ALBO Stock  USD 44.59  0.36  0.80%   
Albireo Pharma competes with Navitas Semiconductor, Sciplay Corp, ON Semiconductor, Canlan Ice, and Playa Hotels; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Albireo Pharma competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Albireo Pharma to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Albireo Pharma competition on your existing holdings. Please continue to Albireo Pharma Correlation with its peers.
  
As of 7th of February 2023, Return on Investment is likely to drop to -81.4. In addition to that, Return on Average Assets is likely to drop to -11.24. Albireo Pharma Tangible Assets Book Value per Share are very stable at the moment as compared to the past year. Albireo Pharma reported last year Tangible Assets Book Value per Share of 13.34. As of 7th of February 2023, Average Assets is likely to grow to about 331.2 M, while Goodwill and Intangible Assets are likely to drop about 16.5 M.